Appili Therapeutics Inc APLIF:OTCQX

RT Quote | Exchange | USD
Last | 08/04/22 EDT
0.0484UNCH (UNCH)
52 week range
0.05 - 0.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0484
  • 52 Week High0.90
  • 52 Week High Date09/30/21
  • 52 Week Low0.05
  • 52 Week Low Date07/15/22

Key Stats

  • Market Cap3.86M
  • Shares Out71.27M
  • 10 Day Average Volume4,828.4
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-46.04

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0484
  • 52 Week High0.90
  • 52 Week High Date09/30/21
  • 52 Week Low0.05
  • 52 Week Low Date07/15/22
  • Market Cap3.86M
  • Shares Out71.27M
  • 10 Day Average Volume4,828.4
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-46.04

RATIOS/PROFITABILITY

  • EPS (TTM)-0.31
  • P/E (TTM)-0.16
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/11/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Appili Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Appili Therapeutics Inc. is a Canada-based biopharmaceutical company. The Company is focused on the acquisition and development of medicines targeting infectious disease. The Company also focused on building and advancing a diverse portfolio of anti-infective programs. Its anti-infective portfolio includes ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir. The ATI-2307 is used for the treatment of invasive fungal infections with a near-term focus on those caused by...
Ian Mortimer
Independent Chairman of the Board
Armand Balboni M.D., Ph.D., J.D.
Chief Executive Officer, Director
Kenneth Howling
Acting Chief Financial Officer
Address
#21-1344 Summer Street
Halifax, NS
B3H 0A8
Canada